|
Neomycin and Polymyxin B Sulfates, Bacitracin Zinc, and Hydrocortisone Acetate Ophthalmic Ointment
» Neomycin and Polymyxin B Sulfates, Bacitracin Zinc, and Hydrocortisone Acetate Ophthalmic Ointment is a sterile ointment containing Neomycin Sulfate, Polymyxin B Sulfate, Bacitracin Zinc, and Hydrocortisone Acetate. It contains the equivalent of not less than 90.0 percent and not more than 140.0 percent of the labeled amounts of neomycin, polymyxin B, and bacitracin, and not less than 90.0 percent and not more than 110.0 percent of the labeled amount of hydrocortisone acetate.
Packaging and storage
Preserve in collapsible ophthalmic ointment tubes.
USP Reference standards
USP Bacitracin Zinc RS. USP Hydrocortisone Acetate RS. USP Neomycin Sulfate RS. USP Polymyxin B Sulfate RS.
Identification
A:
It meets the requirements under Thin-Layer Chromatographic Identification Test
B:
The retention time of the major peak for hydrocortisone acetate in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay for hydrocortisone acetate.
Sterility
Minimum fill
Water, Method I
Metal particles
It meets the requirements of the test for Metal Particles in Ophthalmic Ointments
Assay for neomycin, Assay for polymyxin B, and Assay for bacitracin
Proceed with Ophthalmic Ointment as directed in the Assay for neomycin, in the Assay for polymyxin B, and in the Assay for bacitracin under Neomycin and Polymyxin B Sulfates and Bacitracin Zinc Ophthalmic Ointment.
Assay for hydrocortisone acetate
Proceed with Ophthalmic Ointment as directed in the Assay under Hydrocortisone Acetate Lotion.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
Chromatographic Column
USP32NF27 Page 3060
Pharmacopeial Forum: Volume No. 30(2) Page 519
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.
|